Literature DB >> 10523012

A critical evaluation of simple methods for the estimation of free testosterone in serum.

A Vermeulen1, L Verdonck, J M Kaufman.   

Abstract

The free and nonspecifically bound plasma hormone levels generally reflect the clinical situation more accurately than total plasma hormone levels. Hence, it is important to have reliable indexes of these fractions. The apparent free testosterone (T) concentration obtained by equilibrium dialysis (AFTC) as well as the fraction of serum T not precipitated by 50% ammonium sulfate concentration (non-SHBG-T; SHBG, sex hormone-binding globulin), often referred to as bioavailable T, appear to represent reliable indexes of biologically readily available T, but are not well suited for clinical routine, being too time consuming. Several other parameters have been used without complete validation, however: direct immunoassay of free T with a labeled T analog (aFT), calculation of free T (FT) from total T and immunoassayed SHBG concentrations (iSHBG), and the free androgen index (FAI = the ratio 100T/iSHBG). In the view of substantial discrepancies in the literature concerning the free or bioavailable T levels, we compared AFTC, FT, aFT, FAI, and non-SHBG-T levels in a large number of sera with SHBG capacities varying from low, as in hirsute women, to extremely high as in hyperthyroidism. All these indexes of bioavailable T correlated significantly with the AFTC concentration; AFTC and FT values were almost identical under all conditions studied, except during pregnancy. Values for aFT, however, were only a fraction of either AFTC or FT, the fraction varying as a function of SHBG levels. Also, the FAI/AFTC ratio varied as a function of the SHBG levels, and hence, neither aFT nor FAI is a reliable index of bioavailable T. The FT value, obtained by calculation from T and SHBG as determined by immunoassay, appears to be a rapid, simple, and reliable index ofbioavailable T, comparable to AFTC and suitable for clinical routine, except in pregnancy. During pregnancy, estradiol occupies a substantial part of SHBG-binding sites, so that SHBG as determined by immunoassay overestimates the actual binding capacity, which in pregnancy sera results in calculated FT values that are lower than AFTC. The nonspecifically bound T, calculated from FT, correlated highly significantly with and was almost identical to the values of non-SHBG-T obtained by ammonium sulfate precipitation, testifying to the clinical value of FT calculated from iSHBG.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10523012     DOI: 10.1210/jcem.84.10.6079

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  876 in total

1.  Sex hormones and the risk of incident prostate cancer.

Authors:  Nicholas A Daniels; Carrie M Nielson; Andrew R Hoffman; Douglas C Bauer
Journal:  Urology       Date:  2010-05-07       Impact factor: 2.649

2.  Effect of statins on estrogen and androgen levels in postmenopausal women treated with estradiol.

Authors:  A Peck; S Chaikittisilpa; R Mirzaei; J Wang; W J Mack; H N Hodis; F Z Stanczyk
Journal:  Climacteric       Date:  2010-05-07       Impact factor: 3.005

3.  Mammographic Density and Circulating Sex Hormones: a Cross-Sectional Study in Postmenopausal Korean Women.

Authors:  Kayoung Lee; Jung Eun Yoo; Tuong Linh Nguyen; John Llewelyn Hopper; Yun-Mi Song
Journal:  Horm Cancer       Date:  2018-07-24       Impact factor: 3.869

4.  Musculoskeletal and prostate effects of combined testosterone and finasteride administration in older hypogonadal men: a randomized, controlled trial.

Authors:  Stephen E Borst; Joshua F Yarrow; Christine F Conover; Unyime Nseyo; John R Meuleman; Judyta A Lipinska; Randy W Braith; Darren T Beck; Jeffrey S Martin; Matthew Morrow; Shirley Roessner; Luke A Beggs; Sean C McCoy; Darryl F Cannady; Jonathan J Shuster
Journal:  Am J Physiol Endocrinol Metab       Date:  2013-12-10       Impact factor: 4.310

5.  Endogenous sex steroid hormones and measures of chronic kidney disease (CKD) in a nationally representative sample of men.

Authors:  Stella Yi; Elizabeth Selvin; Sabine Rohrmann; Shehzad Basaria; Andy Menke; Nader Rifai; Eliseo Guallar; Elizabeth A Platz; Brad Astor
Journal:  Clin Endocrinol (Oxf)       Date:  2008-10-21       Impact factor: 3.478

6.  Effect of Roux-en-Y gastric bypass surgery on the sex steroids and quality of life in obese men.

Authors:  Ahmad Hammoud; Mark Gibson; Steven C Hunt; Ted D Adams; Douglass T Carrell; Ronette L Kolotkin; A Wayne Meikle
Journal:  J Clin Endocrinol Metab       Date:  2009-01-27       Impact factor: 5.958

7.  Androgen receptor (CAG)n polymorphism and androgen levels in women with systemic lupus erythematosus and healthy controls.

Authors:  Ralitsa Robeva; Dobromir Tanev; Silvia Andonova; Georgi Kirilov; Alexey Savov; Milena Stoycheva; Analia Tomova; Philip Kumanov; Rasho Rashkov; Zlatimir Kolarov
Journal:  Rheumatol Int       Date:  2013-02-07       Impact factor: 2.631

Review 8.  Endogenous sex hormones, metabolic syndrome, and diabetes in men and women.

Authors:  Catherine Kim; Jeffrey B Halter
Journal:  Curr Cardiol Rep       Date:  2014-04       Impact factor: 2.931

9.  Cross-sectional study of factors influencing sex hormone-binding globulin concentrations in normally cycling premenopausal women.

Authors:  Talia N Crawford; Andrea Y Arikawa; Mindy S Kurzer; Kathryn H Schmitz; William R Phipps
Journal:  Fertil Steril       Date:  2015-09-16       Impact factor: 7.329

10.  Rapid recovery of hypogonadism in male patients with end stage renal disease after renal transplantation.

Authors:  W Reinhardt; H Kübber; S Dolff; S Benson; D Führer; S Tan
Journal:  Endocrine       Date:  2018-02-01       Impact factor: 3.633

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.